Macrophage regulation of tumor angiogenesis: Implications for cancer therapy (Q52610975)

4 May 2018

title

Macrophage regulation of tumor angiogenesis: Implications for cancer therapy (English)

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

1 December 2024

1 reference

1 reference

1 reference

Mario Leonardo Squadrito

1 reference

4 May 2018

Michele De Palma

object named as

Michele De Palma

1 reference

4 May 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21565215

1 December 2024

publication date

1 April 2011

1 reference

4 May 2018

1 May 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21565215

full work available at URL

1 December 2024

https://api.elsevier.com/content/article/PII:S0098299711000203?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

https://api.elsevier.com/content/article/PII:S0098299711000203?httpAccept=text/plain

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Molecular Aspects of Medicine

1 December 2024

published in

1 reference

4 May 2018

volume

1 reference

4 May 2018

issue

1 reference

4 May 2018

page(s)

123-145

1 reference

4 May 2018

Placental growth factor is a survival factor for tumor endothelial cells and macrophages

cites work

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

FcRgamma activation regulates inflammation-associated squamous carcinogenesis.

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

PlGF blockade does not inhibit angiogenesis during primary tumor growth

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Inflammation and cancer: back to Virchow?

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Tumorigenesis and the angiogenic switch

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Modes of resistance to anti-angiogenic therapy

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Three pathways to mature macrophages in the early mouse yolk sac.

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Macrophages promote angiogenesis in human breast tumour spheroids in vivo.

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Systemic and targeted delivery of semaphorin 3A inhibits tumor angiogenesis and progression in mouse tumor models

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Tumor-associated macrophages: the double-edged sword in cancer progression.

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways.

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Angiopoietin 2 stimulates TIE2-expressing monocytes to suppress T cell activation and to promote regulatory T cell expansion.

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions.

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Sema4D induces angiogenesis through Met recruitment by Plexin B1

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

1 December 2024

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

HIF-1alpha is essential for myeloid cell-mediated inflammation

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Targeting cyclooxygenase-2 in human neoplasia: rationale and promise

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

VEGFR1-activity-independent metastasis formation.

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Cancer: Macrophages limit chemotherapy

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Paradoxical roles of the immune system during cancer development

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Gene expression profiling of cutaneous wound healing

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Tumors as organs: complex tissues that interface with the entire organism

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Inflammatory exposure and historical changes in human life-spans

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Myeloid-derived suppressor cells as regulators of the immune system

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Tumor response to radiotherapy regulated by endothelial cell apoptosis

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Alternative activation of macrophages: mechanism and functions

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Immunity, Inflammation, and Cancer

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Blockade of the Stromal Cell–Derived Factor-1/CXCR4 Axis AttenuatesIn vivoTumor Growth by Inhibiting Angiogenesis in a Vascular Endothelial Growth Factor–Independent Manner

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

"Re-educating" tumor-associated macrophages by targeting NF-kappaB.

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Vascular targeting therapy: potential benefit depends on tumor and host related effects

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Specifically Targeting Angiopoietin-2 Inhibits Angiogenesis, Tie2-Expressing Monocyte Infiltration, and Tumor Growth

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Tie-ing the antiinflammatory effect of angiopoietin-1 to inhibition of NF-kappaB

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Mast cells and tumor angiogenesis

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Mannose receptor-mediated regulation of serum glycoprotein homeostasis

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Distinct role of macrophages in different tumor microenvironments

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Macrophages regulate the angiogenic switch in a mouse model of breast cancer

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Tumor-associated macrophages press the angiogenic switch in breast cancer.

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Cancer-related inflammation

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells.

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

M-1/M-2 macrophages and the Th1/Th2 paradigm

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Contribution of monocytes/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardium

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Vascular endothelial growth factor receptor-1 signaling promotes mobilization of macrophage lineage cells from bone marrow and stimulates solid tumor growth

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues.

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

The role of myeloid cells in the promotion of tumour angiogenesis

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Expression of Tie-2 by human monocytes and their responses to angiopoietin-2

1 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Relationships between tumor-associated macrophages and clinicopathological factors in patients with colorectal cancer

1 December 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Dysadherin: a new player in cancer progression

1 December 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Host-derived angiopoietin-2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth

1 December 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

The semaphorins: versatile regulators of tumour progression and tumour angiogenesis

1 December 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis

1 December 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors

1 December 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

1 December 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Activation or destruction of T cells via macrophages

1 December 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Myeloid-derived suppressor cells: linking inflammation and cancer

1 December 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

1 December 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response

1 December 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Myeloid-derived suppressor cell heterogeneity and subset definition.

1 December 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Trophic macrophages in development and disease

1 December 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Activated macrophages induce vascular proliferation

1 December 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships

1 December 2024

114

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages

1 December 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth

1 December 2024

116

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth

1 December 2024

117

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Macrophage diversity enhances tumor progression and metastasis

1 December 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence

1 December 2024

119

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment

1 December 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF

1 December 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer

1 December 2024

122

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts

1 December 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma

1 December 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression

1 December 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Oncogene-driven intrinsic inflammation induces leukocyte production of tumor necrosis factor that critically contributes to mammary carcinogenesis

1 December 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands

1 December 2024

128

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2

1 December 2024

129

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors.

1 December 2024

130

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents

1 December 2024

131

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

The Tumor-Immune Microenvironment and Response to Radiation Therapy

1 December 2024

132

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Refractoriness to antivascular endothelial growth factor treatment: role of myeloid cells

1 December 2024

133

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells.

1 December 2024

134

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Bv8 regulates myeloid-cell-dependent tumour angiogenesis

1 December 2024

135

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Altered macrophage differentiation and immune dysfunction in tumor development

1 December 2024

136

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction

1 December 2024

137

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages

1 December 2024

138

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Macrophages predict treatment outcome in Hodgkin's lymphoma

1 December 2024

139

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

1 December 2024

140

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation

1 December 2024

141

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis

1 December 2024

142

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

1 December 2024

143

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Semaphorins and their receptors in immune cell interactions.

1 December 2024

144

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.

1 December 2024

145

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis

1 December 2024

146

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages

1 December 2024

147

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Angiopoietin-2 stimulation of endothelial cells induces alphavbeta3 integrin internalization and degradation

1 December 2024

148

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B

1 December 2024

149

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer

1 December 2024

151

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Inflammation and necrosis promote tumour growth

1 December 2024

152

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin-like pro-protein convertases

1 December 2024

153

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer.

1 December 2024

154

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential

1 December 2024

155

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice

1 December 2024

156

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors

1 December 2024

157

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

1 December 2024

158

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach

1 December 2024

159

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.

1 December 2024

160

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients

1 December 2024

161

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

Nomenclature of monocytes and dendritic cells in blood.

1 December 2024

162

1 reference

https://api.crossref.org/works/10.1016/J.MAM.2011.04.005

1 December 2024

Identifiers

1 reference

4 May 2018

1 reference

4 May 2018